CNS disorders company Sage Therapeutics Inc. (NASDAQ:SAGE) proposed Monday to raise $500 million in a follow-on underwritten by Goldman Sachs and J.P. Morgan.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,